Efficacy and safety of combined doxofylline and salbutamol in treatment of acute exacerbation of chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Efficacy and safety of combined doxofylline and salbutamol in treatment of acute exacerbation of chronic obstructive pulmonary disease

Published:2021-09 Issue:9 Volume:67 Page:1256-1260
ISSN:1806-9282
Container-title:Revista da Associação Médica Brasileira
language:
Short-container-title:Rev. Assoc. Med. Bras.

Author:

Du Xianrong¹^ORCID,Bao Hongju²^ORCID,Zhao Daguo³^ORCID

Affiliation:

1. Shanxi Provincial People's Hospital, China

2. Sozhou Ninth People's Hospital, China

3. The First Affiliated Hospital of Soochow University, China

Publisher

FapUNIFESP (SciELO)

Subject

General Medicine

Reference14 articles.

1. Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review;Singh JM;Arch Intern Med,2002

2. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease;Matkovic Z;Respiration,2012

3. Transition of patients with COPD across different care settings: challenges and opportunities for hospitalists;Chuang C;Hosp Pract (1995),2012

4. Impact of doxofylline in COPD: A pairwise meta-analysis;Cazzola M;Pulm Pharmacol Ther,2018

5. Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone;Balint B;Int J Chron Obstruct Pulmon Dis,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doxofylline: Advancing and Empowering Equitable Asthma and COPD Management Beyond Tradition;Advanced Therapeutics;2024-06-26

2. Doxofylline in acute exacerbation of chronic obstructive pulmonary disease;Revista da Associação Médica Brasileira;2022-03